Novo Nordisk Stock Rises Ahead of Data on Ozempic Ingredient's Ability to Lower Heart Risk
Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...
STAT1mon
Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders
The Food and Drug Administration has declared an end to the shortage of Novo Nordisk’s blockbuster ... sold under the brand names Ozempic for diabetes and Wegovy for obesity, had been on the ...
Novo Nordisk shares fall on weight-loss drug trial
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...
Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.
Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.
NBC New York29d
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The long-running U.S. shortage of Novo Nordisk's blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the U.S. Food and Drug ...
Wall Street Journal29d
FDA Declares Shortage of Novo Nordisk’s Wegovy, Ozempic Over
The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B0.81%increase; green up pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...
USA Today29d
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...